Intraperitoneal administration of beta-interferon in gastric cancer patients with peritoneal recurrence (ascites and serum IFN levels and its antitumor effect)
Notsuka, T.; Furusawa, M.; Tomoda, H.; Seo, Y.; Kurashige, S.; Kameda, K.; Sonoda, T.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(12): 3538-3540
1986
ISSN/ISBN: 0385-0684 PMID: 3024584 Document Number: 270269
Document emailed within 1 workday
Related Documents
Takashima, S.; Doihara, H.; Yokoyama, N.; Tanada, M.; Soga, H.; Kurita, A.; Takiyama, W.; Saeki, H.; Moriwaki, S. 1990: Intraperitoneal administration of recombinant interferon-beta for prevention in peritoneal metastasis of gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(8 Pt 2): 1600-1603Fujimoto, S.; Shrestha, R.D.; Kokubun, M.; Kobayashi, K.; Kiuchi, S.; Konno, C.; Okui, K. 1990: Clinical results of intraperitoneal hyperthermic perfusion combined with surgery in patients with peritoneal recurrence from gastric cancer Nihon Geka Gakkai Zasshi 91(2): 201-205
Bamba, T.; Kanda, T.; Ohashi, M.; Hanyu, T.; Sakamoto, K.; Ishikawa, T.; Yajima, K.; Makino, S.; Tanabe, T.; Kosugi, S.-i.; Hatakeyama, K. 2005: Safety and efficacy of hypotonic CDDP intraperitoneal administration for gastric cancer with peritoneal dissemination Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(11): 1695-1697
Arai, K.; Iwasaki, Y.; Kimura, Y.; Takahashi, K.; Yamaguchi, T.; Takahashi, T. 2002: Studies of the effectiveness and optimal administration of repeated intraperitoneal chemotherapy for peritoneal dissemination from gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(12): 2160-2163
Fukunaga, H.; Katsumi, M.; Aoki, Y.; Oka, S.; Konishi, R.; Yukawa, H.; Kawaguchi, T.; Tamaki, Y.; Takifuji, K. 1987: 5-FU concentration in tumor tissue and the antitumor effect in patients with gastric cancer after oral administration of UFT Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(9): 2735-2739
Kajiura, Y.; Ogoshi, K.; Nakamura, K.; Miyaji, M.; Kondoh, Y.; Makuuchi, H.; Tajima, T.; Mitomi, T. 1997: Effect of intraperitoneal therapy in gastric cancer with peritoneal dissemination Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(12): 1863-1866
Yonemura, Y.; Endou, Y.; Tochiori, S.; Bando, E.; Kawamura, T.; Shimada, T.; Miyamoto, K.-i.; Tanaka, M.; Sasaki, T. 2005: Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(11): 1635-1639
Tsujitani, S.; Watanabe, A.; Abe, Y.; Maehara, Y.; Sugimachi, K.; Kaibara, N. 1993: Intraperitoneal administration of cisplatin and etoposide during surgery for patients with gastric cancer Anticancer Research 13(6b): 2497-2499
Nagao, S.; Nakano, A.; Moritake, K.; Morikawa, S.; Harada, T. 1997: Synergistic antitumor effects of human interferon-beta and interferon-gamma on human gastric adenocarcinoma cells Human Cell 10(1): 95-104
Xia, W.; Hu, Y.; Mou, T.; Chen, T.; Yu, J.; Li, G. 2014: Safety and efficacy of intraperitoneal hyperthermic perfusion chemotherapy following laparoscopic palliative resection for gastric cancer patients with peritoneal metastasis Zhonghua Wei Chang Wai Ke Za Zhi 17(11): 1087-1091
Yasui, T.; Mizuno, I.; Ichino, T.; Akamo, Y.; Yamamoto, T.; Itabashi, Y.; Saito, T.; Kurahashi, S.; Tanimoto, N.; Yura, J. 1992: Antitumor effect of liposome-entrapped carboplatin after intraperitoneal administration in rats Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1753-1755
Sadłecki, P.ł; Walentowicz-Sadłecka, M.łg.; Szymański, W.ła.; Grabiec, M. 2011: Comparison of VEGF, IL-8 and beta-FGF concentrations in the serum and ascites of patients with ovarian cancer Ginekologia Polska 82(7): 498-502
Saji, S.; Miya, K.; Oshita, H.; Nonomura, O.; Yokoyama, Y.; Yamamoto, S.; Takekoshi, T.; Sakata, K. 1982: Antitumor effect of intraperitoneal administration of a streptococcal preparation, OK-432, in carcinomatous peritonitis. I. Experimental study in the rat Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(11): 1961-1968
Tsujitani, S.; Okuyama, T.; Watanabe, A.; Abe, Y.; Maehara, Y.; Sugimachi, K. 1993: Intraperitoneal cisplatin during surgery for gastric cancer and peritoneal seeding Anticancer Research 13(5c): 1831-1834
Shloma, D.V.; Krispin, T.I.; Balandin, I.G. 1982: Effect of a number of antitumor preparations on RNA- and protein-synthesizing processes and viral interferon induction in Krebs 2 ascites carcinoma cells Voprosy Virusologii 27(6): 735-738
Molina, R.; Jo, J.; Filella, X.; Zanón, G.; Farrus, B.; Muñoz, M.; Latre, M.L.; Pahisa, J.; Velasco, M.; Fernandez, P.; Estapé, J.; Ballesta, A.M. 1999: C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients Anticancer Research 19(4a): 2551-2555
Okamoto, K.; Otsuji, E.; Toma, A.; Kobayashi, S.; Kitamura, K.; Yamaguchi, T.; Yamagishi, H. 2001: Effect of monoclonal antibody-neocarzinostatin conjugate for gastric cancer with peritoneal dissemination--comparison between early and late administration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(11): 1508-1510
Ohgaki, M.; Imanishi, T.; Ohyama, T.; Tsujimoto, H.; Ozaki, K.; Chohei, S.; Shimotsuma, M.; Hagiwara, A.; Takahashi, T. 1994: The prevention of peritoneal dissemination of gastric cancer with intraperitoneal activated carbon particles absorbing mitomycin C Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(13): 2320-2322
Lvovsky, E.A.; D'Souza, J.; Eng, D.; D'Souza, D.; Lvovsky, B.; Hetland, R.; Craver, W.L.; Sobel, S.H. 1988: Tumor response to interferon inducer and radiation effect of serum interferon levels Journal of Biological Regulators and Homeostatic Agents 2(1): 1-6
Hiratsuka, M.; Furukawa, H.; Iwanaga, T.; Nakamori, S.; Masutani, S.; Ohigashi, H.; Kameyama, M.; Sasaki, Y.; Kabuto, T.; Ishikawa, O. 1993: Pharmacokinetics following intraperitoneal sequential administration of cisplatin and fluorouracil for gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(11): 1627-1630